0 Releaf Psychology Ltd 15666829 false 2024-04-22 2025-03-31 2025-03-31 The principal activity of the company is Psychology Digita Accounts Production Advanced 6.30.9574.0 true 15666829 2024-04-22 2025-03-31 15666829 2025-03-31 15666829 bus:Director1 2025-03-31 15666829 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 15666829 bus:Micro-entities 2024-04-22 2025-03-31 15666829 bus:AuditExemptWithAccountantsReport 2024-04-22 2025-03-31 15666829 bus:FilletedAccounts 2024-04-22 2025-03-31 15666829 bus:SmallCompaniesRegimeForAccounts 2024-04-22 2025-03-31 15666829 bus:RegisteredOffice 2024-04-22 2025-03-31 15666829 bus:Director1 2024-04-22 2025-03-31 15666829 bus:PrivateLimitedCompanyLtd 2024-04-22 2025-03-31 15666829 bus:Agent1 2024-04-22 2025-03-31 15666829 countries:EnglandWales 2024-04-22 2025-03-31 xbrli:pure iso4217:GBP

Registration number: 15666829

Releaf Psychology Ltd

Unaudited Filleted Financial Statements

for the Period from 22 April 2024 to 31 March 2025

 

Releaf Psychology Ltd

Contents

Company Information

1

Director's Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

3

 

Releaf Psychology Ltd

Company Information

Director

Dr C Lemaigre

Registered office

89 Brudenell Road
London
SW17 8DD

Accountants

Jordan Ludlow & Associates Limited 9 Limes Road
Beckenham
Kent
BR3 6NS

 

Releaf Psychology Ltd

Director's Report for the Period from 22 April 2024 to 31 March 2025

The director presents her report and the financial statements for the period from 22 April 2024 to 31 March 2025.

This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Incorporation

The company was incorporated on 22 April 2024.

Director of the company

The director who held office during the period was as follows:

Dr C Lemaigre (appointed 22 April 2024)

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 29 May 2025
 

.........................................
Dr C Lemaigre
Director

 

Releaf Psychology Ltd

(Registration number: 15666829)
Balance Sheet as at 31 March 2025

2025
£

Fixed assets

963

Current assets

28,653

Creditors: Amounts falling due within one year

(28,411)

Net current assets

242

Total assets less current liabilities

1,205

Accruals and deferred income

(1,020)

 

185

Capital and reserves

185

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
89 Brudenell Road
London
SW17 8DD
England

These financial statements were authorised for issue by the director on 29 May 2025.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 0.

 

Releaf Psychology Ltd

(Registration number: 15666829)
Balance Sheet as at 31 March 2025

For the financial period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 29 May 2025
 

.........................................
Dr C Lemaigre
Director